- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x 01: Muscimol
01.1: 10 residues within 4Å:- Chain A: F.159, E.217, S.218, Y.219, Y.262, T.265, Y.268
- Chain B: R.125, M.177, S.189
8 PLIP interactions:5 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:Y.219
- Hydrogen bonds: A:E.217, A:S.218, A:T.265, B:R.125, B:S.189
- pi-Stacking: A:Y.262, B:Y.123
01.12: 10 residues within 4Å:- Chain B: F.159, E.217, S.218, Y.219, Y.262, T.265, Y.268
- Chain C: R.125, M.177, S.189
8 PLIP interactions:5 interactions with chain B, 3 interactions with chain C- Hydrophobic interactions: B:Y.219
- Hydrogen bonds: B:E.217, B:S.218, B:T.265, C:R.125, C:S.189
- pi-Stacking: B:Y.262, C:Y.123
01.23: 10 residues within 4Å:- Chain C: F.159, E.217, S.218, Y.219, Y.262, T.265, Y.268
- Chain D: R.125, M.177, S.189
8 PLIP interactions:5 interactions with chain C, 3 interactions with chain D- Hydrophobic interactions: C:Y.219
- Hydrogen bonds: C:E.217, C:S.218, C:T.265, D:R.125, D:S.189
- pi-Stacking: C:Y.262, D:Y.123
01.34: 10 residues within 4Å:- Chain D: F.159, E.217, S.218, Y.219, Y.262, T.265, Y.268
- Chain E: R.125, M.177, S.189
8 PLIP interactions:3 interactions with chain E, 5 interactions with chain D- Hydrogen bonds: E:R.125, E:S.189, D:E.217, D:S.218, D:T.265
- pi-Stacking: E:Y.123, D:Y.262
- Hydrophobic interactions: D:Y.219
01.48: 10 residues within 4Å:- Chain A: R.125, M.177, S.189
- Chain E: F.159, E.217, S.218, Y.219, Y.262, T.265, Y.268
8 PLIP interactions:5 interactions with chain E, 3 interactions with chain A- Hydrophobic interactions: E:Y.219
- Hydrogen bonds: E:E.217, E:S.218, E:T.265, A:R.125, A:S.189
- pi-Stacking: E:Y.262, A:Y.123
- 10 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 25 x OCT: N-OCTANE(Non-covalent)
OCT.4: 2 residues within 4Å:- Chain A: L.286, F.290
Ligand excluded by PLIPOCT.7: 3 residues within 4Å:- Chain A: Y.458, S.459, I.462
Ligand excluded by PLIPOCT.9: 1 residues within 4Å:- Chain A: A.364
Ligand excluded by PLIPOCT.10: 1 residues within 4Å:- Chain A: W.349
Ligand excluded by PLIPOCT.11: 3 residues within 4Å:- Chain A: F.470, I.473, I.477
Ligand excluded by PLIPOCT.15: 2 residues within 4Å:- Chain B: L.286, F.290
Ligand excluded by PLIPOCT.18: 3 residues within 4Å:- Chain B: Y.458, S.459, I.462
Ligand excluded by PLIPOCT.20: 1 residues within 4Å:- Chain B: A.364
Ligand excluded by PLIPOCT.21: 1 residues within 4Å:- Chain B: W.349
Ligand excluded by PLIPOCT.22: 3 residues within 4Å:- Chain B: F.470, I.473, I.477
Ligand excluded by PLIPOCT.26: 2 residues within 4Å:- Chain C: L.286, F.290
Ligand excluded by PLIPOCT.29: 3 residues within 4Å:- Chain C: Y.458, S.459, I.462
Ligand excluded by PLIPOCT.31: 1 residues within 4Å:- Chain C: A.364
Ligand excluded by PLIPOCT.32: 1 residues within 4Å:- Chain C: W.349
Ligand excluded by PLIPOCT.33: 3 residues within 4Å:- Chain C: F.470, I.473, I.477
Ligand excluded by PLIPOCT.37: 2 residues within 4Å:- Chain D: L.286, F.290
Ligand excluded by PLIPOCT.40: 3 residues within 4Å:- Chain D: Y.458, S.459, I.462
Ligand excluded by PLIPOCT.42: 1 residues within 4Å:- Chain D: A.364
Ligand excluded by PLIPOCT.43: 1 residues within 4Å:- Chain D: W.349
Ligand excluded by PLIPOCT.44: 3 residues within 4Å:- Chain D: F.470, I.473, I.477
Ligand excluded by PLIPOCT.45: 1 residues within 4Å:- Chain E: A.364
Ligand excluded by PLIPOCT.46: 1 residues within 4Å:- Chain E: W.349
Ligand excluded by PLIPOCT.47: 3 residues within 4Å:- Chain E: F.470, I.473, I.477
Ligand excluded by PLIPOCT.51: 2 residues within 4Å:- Chain E: L.286, F.290
Ligand excluded by PLIPOCT.54: 3 residues within 4Å:- Chain E: Y.458, S.459, I.462
Ligand excluded by PLIP- 15 x HEX: HEXANE(Non-covalent)
HEX.5: 1 residues within 4Å:- Chain A: W.475
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.475, A:W.475
HEX.6: 2 residues within 4Å:- Chain A: W.304, I.461
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.304, A:I.461
HEX.8: 1 residues within 4Å:- Chain A: L.357
No protein-ligand interaction detected (PLIP)HEX.16: 1 residues within 4Å:- Chain B: W.475
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:W.475, B:W.475
HEX.17: 2 residues within 4Å:- Chain B: W.304, I.461
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:W.304, B:I.461
HEX.19: 1 residues within 4Å:- Chain B: L.357
No protein-ligand interaction detected (PLIP)HEX.27: 1 residues within 4Å:- Chain C: W.475
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:W.475, C:W.475
HEX.28: 2 residues within 4Å:- Chain C: W.304, I.461
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:W.304, C:I.461
HEX.30: 1 residues within 4Å:- Chain C: L.357
No protein-ligand interaction detected (PLIP)HEX.38: 1 residues within 4Å:- Chain D: W.475
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:W.475, D:W.475
HEX.39: 2 residues within 4Å:- Chain D: W.304, I.461
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:W.304, D:I.461
HEX.41: 1 residues within 4Å:- Chain D: L.357
No protein-ligand interaction detected (PLIP)HEX.52: 1 residues within 4Å:- Chain E: W.475
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:W.475, E:W.475
HEX.53: 2 residues within 4Å:- Chain E: W.304, I.461
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:W.304, E:I.461
HEX.55: 1 residues within 4Å:- Chain E: L.357
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fan, C. et al., CryoEM structure of human rho1 GABAA receptor in complex with neurosteroid. To be published
- Release Date
- 2025-07-30
- Peptides
- Gamma-aminobutyric acid receptor subunit rho-1: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x 01: Muscimol
- 10 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 25 x OCT: N-OCTANE(Non-covalent)
- 15 x HEX: HEXANE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fan, C. et al., CryoEM structure of human rho1 GABAA receptor in complex with neurosteroid. To be published
- Release Date
- 2025-07-30
- Peptides
- Gamma-aminobutyric acid receptor subunit rho-1: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.